• Home
  • NEW DAY MEDICINE
  • 4(32)2020
  • 9 -4 (32/1) 2020 — Azizova G.D. — THE EFFECT OF VITAMIN D ON THE DEVELOPMENT OF UTERINE FIBROIDS (LITERATURA REVIEW)

9 -4 (32/1) 2020 — Azizova G.D. — THE EFFECT OF VITAMIN D ON THE DEVELOPMENT OF UTERINE FIBROIDS (LITERATURA REVIEW)

THE EFFECT OF VITAMIN D ON THE DEVELOPMENT OF UTERINE FIBROIDS (LITERATURE REVIEW)

Azizova G.D. -State Institution Republican Specialized Scientific-Practical Medical Center of Obstetrics and Gynecology

Resume

The widespread prevalence of uterine fibroids with a tendency to “eeuueenate» the disease and the complexity of the choice of treatment tactics is a serious problem for practical health care. Early prevention as well as early treatment of uterine fibroids in high-risk women are priority actions.

Key words: vitamin D, uterine myoma, leiomyoma, vitamin D receptor

First page

47

Last page

51

For citation: Azizova G.D., The effect of vitamin d on the development of uterine fibroids (literature review)//New Day in Medicine 4(32)2020 47-51 https://cutt.ly/Yl4GcHd

List of Refereces

  1. Stewart, E.A.; Laughlin-Tommaso, S.K.; Catherino, W.H.; Lalitkumar, S.; Gupta, D.; Vollenhoven, B. Uterine fibroids. Nat. Rev. Dis. Primers 2016, 2, 16043.
  2. Al-Hendy, A.; Myers, E.R.; Stewart, E. Uterine fibroids: Burden and unmet medical need. Semin. Reprod. Med. 2017, 35, 473-480.
  3. Ciebiera, M.; Wlodarczyk, M.; Slabuszewska-Jozwiak, A.; Nowicka, G.; Jakiel, G. Influence of vitamin D and transforming growth factor beta3 serum concentrations, obesity, and family history on the risk for uterine fibroids. Fertil. Steril. 2016, 106, 1787-1792.
  4. Wise, L.A. Study of environment lifestyle and fibroids (self): Advancing the field of fibroid epidemiology. J. Women’s Health 2015, 24, 862-864.
  5. Baird, D.D.; Harmon, Q.E.; Upson, K.; Moore, K.R.; Barker- Cummings, C.; Baker, S.; Cooper, T.; Wegienka, G. A prospective, ultrasound-based study to evaluate risk factors for uterine fibroid incidence and growth: Methods and results of recruitment. J. Women’s Health 2015, 24, 907-915.
  6. Halder, S.K.; Osteen, K.G.; Al-Hendy, A. 1, 25-dihydroxyvitamin D3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells. Biol. Reprod. 2013, 89, 150.
  7. Brakta, S.; Diamond, J.S.; Al-Hendy, A.; Diamond, M.P.; Halder, S.K. Role of vitamin D in uterine fibroid biology. Fertil. Steril. 2015, 104, 698-706.
  8. Kim, J.J.; Sefton, E.C. The role of progesterone signaling in the pathogenesis of uterine leiomyoma. Mol. Cell. Endocrinol. 2012, 358, 223-231.
  9. Ciebiera, M.; Lukaszuk, K.; Meczekalski, B.; Ciebiera, M.; Wojtyla, C.; Slabuszewska-Jozwiak, A.; Jakiel, G. Alternative oral agents in prophylaxis and therapy of uterine fibroids-an up-to- date review. Int. J. Mol. Sci. 2017, 18.
  10. Pludowski, P.; Holick, M.F.; Grant, W.B.; Konstantynowicz, J.; Mascarenhas, M.R.; Haq, A.; Povoroznyuk, V.; Balatska, N.; Barbosa, A.P.; Karonova, T.; et al. Vitamin D supplementation guidelines. J. Steroid Biochem. Mol. Biol. 2018, 175, 125-135.
  11. Protic, O.; Toti, P.; Islam, M.S.; Occhini, R.; Giannubilo, S.R.; Catherino, W.H.; Cinti, S.; Petraglia, F.; Ciavattini, A.; Castellucci, M.; et al. Possible involvement of inflammatory/ reparative processes in the development of uterine fibroids. Cell Tissue Res. 2016, 364, 415-427.
  12. Halder, S.; Al-Hendy, A. Hypovitaminosis D and high serum transforming growth factor beta-3: Important biomarkers for uterine fibroids risk. Fertil. Steril. 2016, 106, 1648-1649.
  13. Elkafas, H.; Qiwei, Y.; Al-Hendy, A. Origin of uterine fibroids: Conversion of myometrial stem cells to tumor-initiating cells. Semin. Reprod. Med. 2017, 35, 481-486.
  14. Holdsworth-Carson, S.J.; Zaitseva, M.; Vollenhoven, B.J.; Rogers, P.A. Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues. Mol. Hum. Reprod. 2014, 20, 250-259.
  15. Islam, M.S.; Ciavattini, A.; Petraglia, F.; Castellucci, M.; Ciarmela, P. Extracellular matrix in uterine leiomyoma pathogenesis: A potential target for future therapeutics. Hum. Reprod. Update 2018, 24, 59-85.
  16. Borahay, M.A.; Asoglu, M.R.; Mas, A.; Adam, S.; Kilic, G.S.; Al-Hendy, A. Estrogen receptors and signaling in fibroids: Role in pathobiology and therapeutic implications. Reprod. Sci. 2017, 24, 1235-1244.
  17. Chill, H.H.; Safrai, M.; Reuveni Salzman, A.; Shushan, A. The rising phoenix-progesterone as the main target of the medical therapy for leiomyoma. Biomed. Res. Int. 2017.
  18. Chwalisz, K.; Taylor, H. Current and emerging medical treatments for uterine fibroids. Semin. Reprod. Med. 2017, 35, 510-522.
  19. Heinonen, H.R.; Sarvilinna, N.S.; Sjoberg, J.; Kampjarvi, K.; Pitkanen, E.; Vahteristo, P.; Makinen, N.; Aaltonen, L.A. Med12 mutation frequency in unselected sporadic uterine leiomyomas. Fertil. Steril. 2014, 102, 1137-1142.
  20. Halder, S.K.; Laknaur, A.; Miller, J.; Layman, L.C.; Diamond, M.; Al-Hendy, A. Novel med12 gene somatic mutations in women from the southern united states with symptomatic uterine fibroids. Mol. Genet. Genom. 2015, 290, 505-511.
9-47-51-4-32-2020-тиббиёт-25-12-2020-—-копия

file

download